Omnicell’s stock tumbled nearly 10% despite beating Q2 earnings—revenue of $312M and 94 cents per share—because investors are spooked by weak forward guidance for the next quarter. The company’s been on a wild ride this year, down 18%, and long-term holders are reeling after a $1,000 investment five years ago is now worth just $250. While past performance was solid, the market’s laser focus on future outlook is driving the sell-off—classic investor behavior when the next quarter’s forecast casts a shadow over today’s success.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
